Search Results 721-730 of 18077 for Alopecia
Any unresolved toxicities from prior therapy greater than CTCAE Grade 1 at the time of starting study treatment with the exception of alopecia and Grade 2, ...
0], with the exception of persistent alopecia, hypothyroidism, and adrenal insufficiency) due to prior treatment. NOTE: Subjects previously treated with a ...
... alopecia). Participant has congestive heart failure (New York Heart Association) Grade ≥ II; cardiac myopathy, active ischemia, or any other uncontrolled ...
Resolution of all toxicities from prior therapy to ≤ Grade 1 (or baseline) within 1 week prior to the first dose of study drug (excluding alopecia) and ...
Participation eligibility · Vitiligo or alopecia; · Hypothyroidism (e.g., following Hashimoto syndrome) stable on hormone replacement; · Any chronic skin condition ...
... alopecia and Grade 2 peripheral neuropathy. HIV infected patients must be on anti-retroviral therapy (ART) and have a well-controlled HIV infection/disease ...
... alopecia. Patients with clinical signs of central nervous system (CNS) involvement of MM. Patients with known or suspected light chain amyloidosis of any ...
It is not a cure for alcoholism, but rather will help you maintain abstinence. This medicine is available only with your doctor's prescription. This product is ...
... alopecia (Grade 2 or 3 toxicities from prior antitumor therapy that are considered irreversible [defined as having been present and stable for > 6 months] ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.